Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase)

Min-Taek Lee, Ju Won Lee, Hyeon Ji Lee, Jong-Min Lee, Jae Chol Choi, Kang-Mo Gu, Sun-Young Jung · 2023

Read Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase) by Min-Taek Lee, Ju Won Lee, Hyeon Ji Lee, Jong-Min Lee, Jae Chol Choi, Kang-Mo Gu, Sun-Young Jung (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10729117.txt.

Description

Min-Taek Lee and co-authors check safety reports for a lung signal after COVID vaccination, in a 2023 study. Case reports had raised the question of interstitial lung disease following the shots, but no population-scale study existed. The team mined the VigiBase database of side effects, covering the first two years of the rollout, and compared reporting rates for COVID vaccines against all other vaccines.

Of about 1.2 million vaccine-related reports, six hundred and seventy-nine concerned the disease. Most involved the leading messenger RNA vaccine, then a viral vector one, then the second RNA vaccine. The odds for COVID vaccines came out slightly below one, meaning no excess signal, and the same held against influenza vaccines, known to cause the condition. The authors say results can inform later vaccination strategy for lung patients, while asking for larger prospective studies.

Catalog record

CREATORMin-Taek Lee, Ju Won Lee, Hyeon Ji Lee, Jong-Min Lee, Jae Chol Choi, Kang-Mo Gu, Sun-Young Jung
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10729117

Browse the full library · About the Tower of Babel